Key Quantitative Figures
- Total Funds Raised: Rs 966.30 crore through preferential allotment
- Breakdown of Funds Received:
- Equity Shares: Rs 400.00 crore
- Warrants (25% upfront): Rs 162.50 crore
- Warrant exercise payments: Rs 403.80 crore
- Funds Utilized: Rs 831.61 crore out of Rs 966.30 crore raised
- Utilization by Object:
- Debt Repayment: Rs 109.64 crore (against allocated Rs 110.00 crore)
- Investment in Subsidiaries: Rs 611.49 crore (against allocated Rs 690.00 crore)
- General Corporate Purposes: Rs 110.48 crore (against allocated Rs 250.00 crore)
Dates of Action
- Allotment Dates: 2nd August 2024, 5th October 2024, 27th October 2025, 4th November 2025, 25th November 2025, 23rd January 2026, 28th January 2026
- Quarter Ended: 30th June, 2026
- Audit Committee Meeting: 7th August, 2026
- Filing Date: 7th August, 2026
Parties Involved
- Monitoring Agency: CARE Ratings Limited
- Signatories: Anup Kumar Jain (Company Secretary), Govind Prakash Rathor (Chief Financial Officer)
- Regulatory Recipients: BSE Limited, National Stock Exchange of India Limited
Utilization Details
Debt Repayment:
- Original Allocation: Rs 110.00 crore
- Modified Allocation: Rs 109.64 crore
- Actual Utilized: Rs 109.64 crore
- Status: Completed, no deviation
Investment in Subsidiaries:
- Original Allocation: Rs 690.00 crore
- Modified Allocation: Rs 621.00 crore
- Actual Utilized: Rs 611.49 crore
- Status: No deviation
General Corporate Purposes:
- Original Allocation: Rs 250.00 crore
- Modified Allocation: Rs 235.66 crore
- Actual Utilized: Rs 110.48 crore
- Status: No deviation
Audit Committee Review
The Audit Committee reviewed and noted the statement of nil deviation/variation in their meeting held on 7th August, 2026. No comments were provided by the Audit Committee or auditors.
Financial Impact
No financial impact from deviation/variation as the company confirmed nil deviation in fund utilization compared to the objects stated in the offer document.